TABLE 1.
Characteristics of the intestinal donors (n = 21) from whom relevant information was available
| HI | Sex | Age | Race/Ethnicity | Chronic Medications | Disease |
|---|---|---|---|---|---|
| yr | |||||
| 1 | F | 57 | W | Digoxin, theophylline, aspirin, alcohol abuse, smoker | Hypertension, COPD, cirrhosis |
| 2 | F | 14 | AA | None | |
| 5 | M | 34 | W | Smoker | |
| 19A | F | 52 | W | β-Blocker | Hypertension |
| 19B | F | 44 | W | None | |
| 22 | F | 50 | W | Conjugated estrogens (1 week) | |
| 23A | M | 39 | W | Terfenadine, sertraline, verapamil | |
| 23B | M | 23 | W | Alcohol abuse | |
| 24 | F | 52 | W | Conjugated estrogens, progesterone | |
| 28 | F | 33 | W | Alprazolam, doxepin, Caffergot | |
| 29 | M | 39 | W | Marijuana abuse, alcohol abuse, smoker | Diabetes |
| 30 | M | 30 | W | Alcohol abuse | |
| 32 | M | 16 | A | None | |
| 35 | M | 16 | H | Asthma | |
| 36 | F | 48 | W | Terfenadine | Asthma, morbid obesity |
| 38 | F | 59 | W | Ibuprofen | |
| 40 | F | 21 | W | None | |
| 42 | M | 21 | W | None | |
| 44 | F | 64 | W | Medihaler, Estrace, Provera, warfarin | Heart disease, asthma |
| 45 | F | 13 | W | None | |
| 46 | M | 44 | W | Alcohol abuse, smoker |
W, white; AA, African American; A, Asian; H, Hispanic; COPD, chronic obstructive pulmonary disease.